Astria Therapeutics, Inc. (ATXS) has a market capitalization of $718.13M and trades at $12.58. The 52-week range is 3.555-13.29.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.5, Earnings Per Share (EPS) of $-1.67.
The stock has a beta of 0.02, operates in the Healthcare sector.
